An approach for rapid development of nasal delivery of analgesics - Identification of relevant features, in vitro screening and in vivo verification

International Journal of Pharmaceutics

Volumn 420, Issue 1, 2011, Pages 43-50

  Wang, Shu ^a   Chow, Moses S S ^b   Zuo, Zhong ^a  

^a Prince of Wales Hospital   (Hong Kong)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Analgesics; Calu 3; Meloxicam; Nasal administration; Permeability; Pharmacokinetics

Indexed keywords

LORNOXICAM; MELOXICAM; NEBIVOLOL; RIZATRIPTAN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; DRUG STABILITY; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT;

ABSORPTION; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; AREA UNDER CURVE; BENZOPYRANS; CELL LINE; DRUG STABILITY; ETHANOLAMINES; FEASIBILITY STUDIES; HUMANS; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRAVENOUS; MALE; NASAL MUCOSA; PERMEABILITY; PIROXICAM; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; RESPIRATORY MUCOSA; THIAZINES; THIAZOLES; TRIAZOLES; TRYPTAMINES;

EID: 80054705192     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.08.019     Document Type: Article

References (26)

1. C.R. Behl, H.K. Pimplaskar, A.P. Sileno, J. deMeireles, and V.D. Romeo Effects of physicochemical properties and other factors on systemic nasal drug delivery Adv. Drug Deliv. Rev. 29 1998 89 116 (Pubitemid 28044088)
2. U. Busch, J. Schmid, G. Heinzel, H. Schmaus, J. Baierl, C. Huber, and W. Roth Pharmacokinetics of meloxicam in animals and the relevance to humans Drug Metab. Dispos. 26 1998 576 584 (Pubitemid 28498364)
3. G. Cheymol, J.M. Poirier, P.A. Carrupt, B. Testa, J. Weissenburger, J.C. Levron, and E. Snoeck Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers Br. J. Clin. Pharmacol. 43 1997 563 570 (Pubitemid 27283564)
4. D.C. Corbo, J.C. Liu, and Y.W. Chien Characterization of the barrier properties of mucosal membranes J. Pharm. Sci. 79 1990 202 206 (Pubitemid 20146482)
5. N.M. Davies, and N.M. Skjodt Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug Clin. Pharmacokinet. 36 1999 115 126 (Pubitemid 29121685)
6. S.S. Davis, and L. Illum Absorption enhancers for nasal drug delivery Clin. Pharmacokinet. 42 2003 1107 1128 (Pubitemid 37357648)
7. L. Euller-Ziegler, P. Vélicitat, E. Bluhmki, D. Türck, S. Scheuerer, and B. Combe Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration Inflamm. Res. 50 Suppl. 1 2001 S5 S9
8. B.I. Florea, M. Thanou, H.E. Junginger, and G. Borchard Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation J. Control. Release 110 2006 353 361 (Pubitemid 41827489)
9. K.A. Foster, M.L. Avery, M. Yazdanian, and K.L. Audus Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery Int. J. Pharm. 208 2000 1 11
10. C.I. Grainger, L.L. Greenwell, D.J. Lockley, G.P. Martin, and B. Forbes Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier Pharm. Res. 23 2006 1482 1490 (Pubitemid 43993811)
11. H.K. Han, and H.K. Choi Improved absorption of meloxicam via salt formation with ethanolamines Eur. J. Pharm. Biopharm. 65 2007 99 103
12. G. Hitzenberger, S. Radhofer-Welte, F. Takacs, and D. Rosenow Pharmacokinetics of lornoxicam in man Postgrad. Med. J. 66 Suppl. 4 1990 S22 S27
13. L. Li, N.R. Mathias, C.L. Heran, P. Moench, D.A. Wall, and R.L. Smith Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers J. Pharm. Sci. 95 2006 326 335 (Pubitemid 43241975)
14. P. Luger, K. Daneck, W. Engel, G. Trummlitz, and K. Wagner Structure and physicochemical properties of meloxicam, a new NSAID Eur. J. Pharm. Sci. 4 1996 175 187 (Pubitemid 26174671)
15. N.R. Mathias, J. Timoszyk, P.I. Stetsko, J.R. Megill, R.L. Smith, and D.A. Wall Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats J. Drug Target. 10 2002 31 40 (Pubitemid 34223847)
16. H.M. Nielsen, and M.R. Rassing TR146 cells grown on filters as a model of human buccal epithelium. IV. Permeability of water, mannitol, testosterone and beta-adrenoceptor antagonists. Comparison to human, monkey and porcine buccal mucosa Int. J. Pharm. 194 2000 155 167 (Pubitemid 30110678)
17. K.T. Olkkola, A.V. Brunetto, and M.J. Mattila Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents Clin. Pharmacokinet. 26 1994 107 120 (Pubitemid 24064235)
18. Penkler JL, Whittaker DV. Pharmaceutical compositions containing lornoxicam and cyclodextrin. International Publication Number: WO 96/41646.
19. I. Pezron, R. Mitra, D. Pal, and A.K. Mitra Insulin aggregation and asymmetric transport across human bronchial epithelial cell monolayers (Calu-3) J. Pharm. Sci. 91 2002 1135 1146 (Pubitemid 34640938)
20. W. Riad, and A. Moussa Lornoxicam attenuates the haemodynamic responses to laryngoscopy and tracheal intubation in the elderly Eur. J. Anaesthesiol. 25 2008 732 736
21. Y. Rojanasakul, L.Y. Wang, M. Bhat, D.D. Glover, C.J. Malanga, and J.K. Ma The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit Pharm. Res. 9 1992 1029 1034
22. T. Seki, H. Kanbayashi, S. Chono, Y. Tabata, and K. Morimoto Effects of a sperminated gelatin on the nasal absorption of insulin Int. J. Pharm. 338 2007 213 218 (Pubitemid 46777241)
23. D. Türck, W. Roth, and U. Busch A review of the clinical pharmacokinetics of meloxicam Br. J. Rheumatol. 35 Suppl. 1 1996 13 16
24. C. Wadell, E. Björk, and O. Camber Permeability of porcine nasal mucosa correlated with human nasal absorption Eur. J. Pharm. Sci. 18 2003 47 53 (Pubitemid 36120554)
25. Y. Wang, Z. Zuo, K.K.H. Lee, and M.S.S. Chow Evaluation of HO-1-u-1 cell line as an in vitro model for sublingual drug delivery involving passive diffusion - initial validation studies Int. J. Pharm. 334 2007 27 34 (Pubitemid 46400308)
26. C. Witschi, and R.J. Mrsny In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery Pharm. Res. 16 1999 382 390 (Pubitemid 29162095)